1. Suh GH. Dementia in Korea: trend and projection. J Korean Geriatr Psychiatry 2002;6:79-87.
2. Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, et al. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008;148:370-378. PMID:
18316755.
3. Suh GH. Drug therapy for Alzheimer's disease. J Korean Med Assoc 2007;50:369-374.
4. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. PMID:
10190820.
5. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763-765. PMID:
9074575.
6. Braak H, Tredici KD, Braak E. In: Petersen RC, editor. Mild cognitive impairment: aging to Alzheimer's disease. Spectrum of pathology. 2003. New York: Oxford University Press; p. 149-189.
7. Han SH. Novel pharmacotherapies for Alzheimer's disease. J Korean Med Assoc 2009;52:1059-1068.
8. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008;13:45-53. PMID:
18204414.
9. Haan MN, Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 2004;25:1-24. PMID:
15015910.
10. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057-1064. PMID:
18367704.
11. Park MS, Cho BL, Yang DW, Kim SY. A validation study of a Korean version of the 7-Minute Screen test. J Korean Acad Fam Med 2002;23:728-739.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572. PMID:
12748199.
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421. PMID:
12485966.
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5-S20. PMID:
12502614.
15. Park MS, Lee JU, Yang JH, Cho BL, Yang DW, Kim SY. Standardization of Korean version of 7-Minute Screen test. J Korean Neurol Assoc 2002;20:252-259.
16. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux RD, et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 1998;55:349-355. PMID:
9520009.
17. Kim DK, Kim KS, Yang JH, Lee HJ, Koh HJ, Cho B, et al. Clinical efficacy of the 7-Minute Screen at primary care setting. J Korean Acad Fam Med 2000;21:1131-1138.
18. Bassett J. International Diabetes Institute. World Health Organization, Regional Office for the Western Pacific. International Association for the Study of Obesity. International Obesity Task Force. The Asia Pacific perspective: redefining obesity and its treatment. 2000. Sydney: Health Communications Australia.
19. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes 2006;15:1-9.
20. Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA 2000;283:1615-1617. PMID:
10735401.
21. Lathe R. Hormones and the hippocampus. J Endocrinol 2001;169:205-231. PMID:
11312139.
22. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004;181:1-10. PMID:
15072562.
23. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 2004;18:1870-1878. PMID:
15576490.
24. Bjorntorp P, Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord 2000;24(Suppl 2):S80-S85. PMID:
10997616.
25. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222. PMID:
12660385.
26. Waldstein SR, Siegel EL, Lefkowitz D, Maier KJ, Brown JR, Obuchowski AM, et al. Stress-induced blood pressure reactivity and silent cerebrovascular disease. Stroke 2004;35:1294-1298. PMID:
15087554.
27. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005;64:494-500. PMID:
15699381.
28. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918. PMID:
16380542.
29. Jeong SK, Nam HS, Son MH, Son EJ, Cho KH. Interactive effect of obesity indexes on cognition. Dement Geriatr Cogn Disord 2005;19:91-96. PMID:
15591798.